Educating Diabetes Healthcare Professionals Worldwide
Proven Outcomes.*Beyond Trials.
Learn more about the MiniMed™ 670G system outcomes and how this hybrid closed loop therapy can help your patients.
THE MINIMED™ 670G SYSTEM IS NOWAVAILABLE FOR CHILDREN 7 YEARS OF AGE AND OLDER!
THE WORLD’S FIRST SMART CGM.1
For people using insulin injections.
Professional CGM reimbursement interactive
Learn more about potential clinical & economic benefits of Professional CGM for your practice.
- Medicare Reimbursement Rates
- Commercial Payer Policies
- Sample Economic Model
What information can we help you find today?
I want to learn more about the latest advancements in insulin pump therapy.
AUTOMATICALLY ADJUSTS TO YOUR PATIENT'S LIFE.
Insulin pump therapy provides more flexibility for your patients’ lifestyle while giving them greater control of their diabetes. The MiniMed™ 670G insulin pump system is revolutionary new technology that mimics some of the functions of a healthy pancreas.
MINIMED™ 670G SYSTEM.
Now approved for patients ages 7 and up.
I am looking for smart CGM solutions for my patients currently on multiple daily injections.
SMART CGM FOR PATIENTS ON MDI.
Now your patients may experience fewer lows and highs. The Guardian™ Connect CGM system monitors glucose levels day and night, sending precise readings automatically to the app. The system includes a small sensor, Guardian™ Sensor 3, that can be worn up to seven days and a slim, discreet Bluetooth® transmitter that can be worn in almost any situation. They work together to send precise glucose readings every five minutes.
SUGAR.IQ™ PERSONAL DIABETES ASSISTANT.
Help patients understand their daily glucose patterns and identify activities affecting them — for a full picture of their diabetes.†
GUARDIAN™ CONNECT CGM SYSTEM.
The clearly smarter way to help patients experience fewer highs and lows.
The only CGM system that can alert your patients of potential highs and lows up to 60 minutes in advance.
AUTOMATIC UPLOADS TO CARELINK™ SYSTEM.
Seamlessly and conveniently access your patients daily sensor glucose readings directly from your practice.
I am seeking tools that will allow me and my patients to visualize diabetes information with simple charts and statistics.
COMPREHENSIVE INSIGHTS FOR WELL-INFORMED DECISIONS. CARELINK™ REPORTS.
CareLink™ reports help you visualize your patient’s diabetes information with charts and statistics; making your job easier. The data is delivered in a way to help you make recommendations you are confident about. CareLink™ reports intelligently analyze all the data to highlight observations and patterns.
of clinical diabetes educators choose CareLink™ as their preferred diabetes software∆ .
DO A QUICK CHECK OR TAKE A DEEP DIVE.
With an array of new reports, CareLink™ software makes it easier than ever to quickly assess and track your patients progress.
iPro™2 professional CGM evaluation.
Easily interpret patient CGM data with simple CareLink™ iPro™ Pattern Snapshot reports.
1. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Prrukcheewanont P: A pilot study of the continuous glucose monitoring system, Diabetes Care. 2001;24(12):2030−2034 2. Compared to self-monitored blood glucose alone.
† The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.
∆ dQ&A Diabetes Educator Perspectives Survey, Q3 2015. 428 total respondents.
§ Customer training phase – data on file.
# Data on File. Data from CareLink™ personal software uploads in the US from March 2017 to May 2019; patient days = 6,285,416. 212,173 total predicted hypo events avoided in April 2019. Lows refers to sensor glucose values < 70mg/dL. Highs refers to sensor glucose values > 180 mg/dL.